BeiGene Ltd. (Stock Code: 06160) disclosed that 4,431 eligible employees completed share purchases under its Fifth Amended and Restated 2018 Employee Share Purchase Plan (2018 ESPP) for the six-month offering period ended 27 February 2026.

The purchase resulted in 57,023 American depositary shares (ADSs), equating to 741,299 ordinary shares and representing about 0.05 % of BeiGene’s total outstanding share capital as of the announcement date.

Key transaction parameters • Purchase price: USD 269.44 per ADS (approximately HKD 162.08 per ordinary share), reflecting 85 % of the lower closing price between the first and last trading days of the offering period. • Aggregate payroll deductions: USD 15.88 million collected from participating employees over the six months.

Plan mechanics and governance • Discount: 15 % to market price, consistent with plan provisions. • Participants: Exclusively employees; no directors, chief executives, substantial shareholders, related-entity participants, or service providers exceeded Hong Kong Listing Rule thresholds. • Performance & clawback: No performance targets or clawback mechanism apply; purchases are subject to standard tax withholding. • Financing: Neither BeiGene nor its subsidiaries provided financial assistance for share purchases.

Capacity for future grants After this transaction, 2.44 million shares remain available for issuance under the 2018 ESPP, supporting continued employee participation in future offering periods.

BeiGene’s board views the ESPP as a tool to align employee and shareholder interests and bolster long-term retention.